Karl Härfstrand
Founder at Härfstrand Consulting AG
Net worth: - $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Johan Luthman | M | 65 |
Karolinska Institutet
| 7 years |
| Daniel Welch | M | 66 | - | |
| Oleg Nodelman | M | 47 | 5 years | |
| Hege Hellstrom | M | 59 | 5 years | |
| Brandon Smith | M | 50 | 4 years | |
| Theresa Tse | F | 32 | 7 years | |
| Robert Maiorana | M | 64 | 4 years | |
| Michael J. Malecek | M | 58 | 5 years | |
| Paula Cobb | F | 51 | 5 years | |
| Helen Kim | F | 61 | 2 years | |
| Michael Bachner | M | - | 2 years | |
| Johanna Röstin | F | 57 | 3 years | |
| Michael MacDougall | M | - |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 17 years |
| Roger Tell | M | 59 | 2 years | |
| Antonio Lanzavecchia | M | 73 |
Humabs BioMed SA
 Humabs BioMed SA Miscellaneous Commercial ServicesCommercial Services Humabs BioMed SA is an antibody therapeutics biotechnology company. It develops human monoclonal antibody platforms for treatment of infectious and inflammatory diseases. The company was founded by Prof. Antonio Lanzavecchia on October 24, 2011 and is headquartered in Bellinzona, Switzerland. | 13 years |
| Carol Karp | F | 71 | 8 years | |
| Pål Ryfors | M | 41 | 2 years | |
| Hideki Garren | M | 60 | 3 years | |
| William Dunn | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jim van Heusden | M | 53 | 2 years | |
| Peter Arend William Burema | M | 66 | 3 years | |
| Hanne Leth Hillman | F | 59 | 3 years | |
| Lars Terney | M | - | 2 years | |
| Dale B. Schenk | M | 66 | 4 years | |
| Ulrik Ditlev Eriksen | M | - | 10 years | |
| John Weiland | M | 68 |
Pharmacia AB
| - |
| Andrea Buscaglia | M | 60 |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | 4 years |
| Achim Schäffler | M | - |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | 6 years |
| François Martelet | M | 64 | 2 years | |
| Jan Hermansson | M | 68 |
Pharmacia & Upjohn, Inc.
Karolinska Institutet
| 7 years |
| Lynn A. Taylor | F | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Gunnar Magnus Modee Persson | M | 64 | 3 years | |
| Robert Schmid | M | 65 | - | |
| Sanjiv Patel | M | 50 | 2 years | |
| Henrijette Richter | M | 53 | 3 years | |
| Jennifer Zibuda | F | - | 3 years | |
| Gunilla Öhman | F | 65 | 1 years | |
| Carl Johan Bertil Sundberg | M | 66 | 3 years | |
| Fredrik Järrsten | M | 57 | 4 years | |
| Kim Arvid Nielsen | M | 65 | 3 years | |
| Bo Jesper Hansen | M | 66 | 4 years | |
| Martin D. Meglasson | M | 74 |
Pharmacia, Inc.
Pharmacia & Upjohn, Inc.
| 7 years |
| Tara Nickerson | M | 51 | 6 years | |
| Fred Hassan | M | 78 |
Pharmacia & Upjohn, Inc.
| 3 years |
| Christopher Henney | M | 83 | 9 years | |
| Gilles V. J. Pajot | M | 74 |
Pharmacia & Upjohn, Inc.
Pharmacia AB
| 3 years |
| Jonas Nilsen | M | - | 4 years | |
| Richard Åhlberg | M | - |
Karolinska Institutet
| 12 years |
| Carina Eklöw | F | - | 1 years | |
| Göran Albert Ando | M | 75 |
Pharmacia & Upjohn, Inc.
Pharmacia AB
| 8 years |
| Jochen Mattis | M | - |
Horizon Therapeutics Switzerland GmbH
Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | 6 years |
| Ulf Rosén | M | 64 |
Pharmacia & Upjohn, Inc.
| 3 years |
| Arthur William Homan | M | 64 | 5 years | |
| Jessica Martinsson | F | 52 |
Pharmacia & Upjohn, Inc.
| - |
| Mats Norman | M | 61 |
Karolinska Institutet
| 4 years |
| Ruud van Anraat | M | 62 | - | |
| Alice Heezen | F | 54 | 3 years | |
| Carrie Cox | F | 66 |
Pharmacia & Upjohn, Inc.
| - |
| Devin Smith | M | 56 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Karl Magnus Olof Johannes Edner | M | 68 |
Karolinska Institutet
| 6 years |
| Ewa Björling | M | 63 | - | |
| Christer Nordstedt | M | 62 |
Karolinska Institutet
| 5 years |
| Jan-Ingmar Flock | M | 75 |
Karolinska Institutet
| 3 years |
| Annette Eschler | M | 59 | 3 years | |
| Jonathan Freeman | M | 56 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 6 years |
| Desiree Luthman | M | 65 |
Karolinska Institutet
| 3 years |
| Joakim Lindén | M | - | - | |
| Maria Nilsson Hagberg | F | - | 2 years | |
| Heidi Ramstad | M | 55 | - | |
| Daniel Tesfa | M | 55 | - | |
| Laura González Molero | F | 59 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 7 years |
| Lars Gösta Jonsson | M | 83 |
Karolinska Institutet
| 19 years |
| Marcel von Ah | M | 53 | 8 years | |
| Alf E. A. Lindberg | M | 85 |
Karolinska Institutet
| 10 years |
| Ellen Chiniara | F | 65 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 4 years |
| Bob C. Salisbury | M | 80 |
Pharmacia & Upjohn, Inc.
| - |
| Axel B. Müller | M | - | - | |
| Craig Tooman | M | 58 |
Pharmacia & Upjohn, Inc.
| - |
| Reinhard Koenig | M | 64 | - | |
| Mark Corrigan | M | 66 |
Pharmacia & Upjohn, Inc.
| 10 years |
| Carl Harald Janson | M | 66 |
Karolinska Institutet
| 3 years |
| Andreas Rummelt | M | 67 | 2 years | |
| Hans-Olov Olsson | M | 83 | - | |
| Hans Ture Staffan Ek | M | 79 |
Pharmacia AB
| 20 years |
| Luzi Andreas von Bidder | M | 71 | 16 years | |
| Johan Rutger Christenson | M | 65 |
Karolinska Institutet
| 14 years |
| Staffan O. Bjoeoern | M | - | - | |
| Christian Henrik Tange | M | 58 | 3 years | |
| Robert Gorman | M | - |
Pharmacia & Upjohn, Inc.
| - |
| Wenche Nelly A. Rolfsen Sandsborg | M | 72 |
Pharmacia AB
| 16 years |
| James Sapirstein | M | 63 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 3 years |
| Carl-Johan Spak | M | 68 |
Karolinska Institutet
| 9 years |
| Philip Lockwood | M | 75 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 4 years |
| Lars Gunnar Lannfelt | M | 75 |
Karolinska Institutet
| 3 years |
| Bruno C. Musch | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | - |
| Annika Margareta Grahn-Westin | F | - |
Pharmacia AB
| 19 years |
| Inger Birgitta Fogelberg | F | - |
Pharmacia AB
| 10 years |
| Daniel Spasic | M | - |
Pharmacia & Upjohn, Inc.
| - |
| Jürgen Betzing | M | 61 | - | |
| MARIA V BRESNAHAN | M | - |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 45 | 45.00% |
| United States | 23 | 23.00% |
| Ireland | 16 | 16.00% |
| Switzerland | 14 | 14.00% |
| Denmark | 6 | 6.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Karl Härfstrand
- Personal Network
